Biotechnology company developing oral small-molecule Positive Functional Modulators (PFMs) that restore or enhance dysfunctional membrane protein activity
Biotechnology company developing oral small-molecule Positive Functional Modulators (PFMs) that restore or enhance dysfunctional membrane protein activity. Its platform targets ABC transporters and other membrane proteins, with programs for primary sclerosing cholangitis and other hepatobiliary, cardio-renal, metabolic, and neurological diseases.